Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 209,916,103

Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) is 209,916,103 for the year ending December 31, 2023, a 0.55% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 208,775,320, a 2.34% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 203,994,308, a 0.00% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 203,994,308, a 0.00% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 203,994,308, a 0.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years